Replies to post #8671 on Ariad Pharmaceuticals Inc fka ARIA

[qutrader]

I still have hope that the presentation will be positive.

1) At the time Merck and Ariad submitted the abstract, it was already known that the primary results were not stellar and i imagine both Merck and ARIA had a good grasp of the underlying data and O/S data. Why would ARIAD agree to present at ASCO and announce it at every opportunity, if they are going to stink up the joint?

2) I believe Harvey would have already moved forward with an offering in this $8-$9 range if he thought that the stock would tank post-ASCO.